Background Chemotherapy-induced peripheral neuropathy (CIPN) is regarded as one of the
most common dose-limiting adverse effects of several chemotherapeutic agents, such as …

Taxane‐derived drugs are antineoplastic agents used for the treatment of highly common
malignancies. Paclitaxel and docetaxel are the most commonly used taxanes; however …

Oxaliplatin (OHP)-induced peripheral neurotoxicity (OIPN) is a severe clinical problem and
potentially permanent side effect of cancer treatment. For the management of OIPN, accurate …

Although recent scientific advances have improved our understanding of basic biological
mechanisms underlying chemotherapy-induced peripheral neuropathy (CIPN), few …

Taxane‐induced peripheral neurotoxicity (TIPN) is the most common non‐hematological
side effect of taxane‐based chemotherapy, and may result in dose reductions and …

The burdensome condition of chemotherapy-induced peripheral neuropathy occurs with
various chemotherapeutics, including bortezomib, oxaliplatin, paclitaxel and vincristine. The …

Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major dose-limiting side effect of
many anti-cancer agents, including taxanes, platinums, vinca alkaloids, proteasome …

Peripheral neuropathy is one of the most common, dose limiting, and long-lasting disabling
adverse events of chemotherapy treatment. Unfortunately, no treatment has proven efficacy …

Background Recently, the efficacy of cryotherapy and compression therapy to prevent
taxane-induced peripheral neuropathy has been reported. We prospectively compared the …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose limiting, and long-
lasting side effect of chemotherapy treatment. Unfortunately, no treatment has proven …